PROCEPT BioRobotics Management
Management criteria checks 3/4
PROCEPT BioRobotics' CEO is Larry Wood, appointed in Sep 2025, has a tenure of less than a year. directly owns 0.004% of the company’s shares, worth $73.61K. The average tenure of the management team and the board of directors is 2.2 years and 4.4 years respectively.
Key information
Larry Wood
Chief executive officer
US$537.4k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.004% |
| Management average tenure | 2.2yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Is PROCEPT BioRobotics (NASDAQ:PRCT) A Risky Investment?
Sep 26
Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy
Aug 14What You Can Learn From PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S After Its 34% Share Price Crash
Aug 09PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$65.75 Price Target
Aug 08US$77.00: That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After Its Latest Results
Apr 27Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects
Apr 18
HYDROS Robotic System Launch And Aquablation Trials Will Drive Future Market Expansion
Launch of HYDROS Robotic System and FDA approvals likely to increase procedural adoption and drive revenue growth.Procept BioRobotics: Strong Growth, But Profitability Seems Far Away
Mar 11PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$93.86 Price Target
Feb 28What You Can Learn From PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S
Dec 05Procept BioRobotics: Continued Growth Runway Ahead
Nov 26Earnings Update: Here's Why Analysts Just Lifted Their PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target To US$102
Oct 31Procept BioRobotics: New Hydros Aquablation System To Fuel Next Leg Of Growth
Sep 12Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval
Aug 27Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects As Shares Rocket 28%
Aug 25Here's What Analysts Are Forecasting For PROCEPT BioRobotics Corporation (NASDAQ:PRCT) After Its Second-Quarter Results
Aug 04PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S Is Still On The Mark Following 37% Share Price Bounce
May 21The Price Is Right For PROCEPT BioRobotics Corporation (NASDAQ:PRCT)
Apr 05US$56.67 - That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After These Results
Mar 01Despite Lacking Profits PROCEPT BioRobotics (NASDAQ:PRCT) Seems To Be On Top Of Its Debt
Feb 07Market Participants Recognise PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Revenues Pushing Shares 26% Higher
Dec 14CEO
Larry Wood (59 yo)
Mr. Larry L. Wood has been Director of PROCEPT BioRobotics Corporation since April 18, 2024 and is its President and Chief Executive Officer since September 2, 2025. Mr. Wood served as Group President of T...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$537.42k | 0.0043% $ 73.6k | |
| Executive VP & CFO | 7.3yrs | US$2.19m | 0.12% $ 2.1m | |
| EVP, Chief Legal Officer & Corporate Secretary | 7.5yrs | US$2.65m | 0.062% $ 1.1m | |
| Senior Vice President of Operations | less than a year | no data | no data | |
| Executive VP & CTO | 2.2yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief People Officer | 2yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs & Quality Assurance | 4yrs | no data | no data |
Experienced Management: PRCT's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.8yrs | US$537.42k | 0.0043% $ 73.6k | |
| Chairperson of the Board | 1.5yrs | US$355.62k | 0% $ 0 | |
| Independent Director | 14.4yrs | US$255.97k | 1.54% $ 26.5m | |
| Independent Director | 5.1yrs | US$251.39k | 0.24% $ 4.1m | |
| Independent Director | 4.3yrs | US$250.32k | 0.020% $ 339.3k | |
| Independent Director | 4.1yrs | US$241.39k | 0.023% $ 395.4k | |
| Independent Director | 10.6yrs | US$243.89k | 0.086% $ 1.5m | |
| Independent Director | 4.6yrs | US$248.89k | 0.011% $ 187.5k |
Experienced Board: PRCT's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/28 00:32 |
| End of Day Share Price | 2026/01/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PROCEPT BioRobotics Corporation is covered by 23 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| Travis Steed | BofA Global Research |
| Craig Bijou | BofA Global Research |